Skip to main content

GS JT Pill: gray, capsule/oblong, 14mm

Generic Name: pazopanib

The pill with imprint GS JT (Gray, Capsule/Oblong, 14mm) has been identified as Votrient pazopanib 200 mg and is used for Soft Tissue Sarcoma, and Renal Cell Carcinoma. It belongs to the drug class VEGF/VEGFR inhibitors and is not a controlled substance.

Images for GS JT

Votrient pazopanib 200 mg GS JT
Votrient pazopanib 200 mg GS JT

Votrient

Generic Name
pazopanib
Imprint
GS JT
Strength
pazopanib 200 mg
Color
Gray
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate type A potato, hypromelloses, ferrosoferric oxide, polyethylene glycol 400, polysorbate 80, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00078-0670 (Discontinued) Novartis Pharmaceuticals Corporation
00173-0804 (Discontinued) GlaxoSmithKline

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.